NEW YORK, NY--(Marketwire - October 21, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH) a leading developer of regional therapy for liver cancer announced today that President and CEO Richard Taney will participate in a Panel Discussion on "Combination Products: A Convergence of Technologies and Market Opportunities" at the Medical Device & Manufacturing Conference, Oct 22, 2008, 12:30pm-1:15pm at the Minneapolis Convention Center. Mr. Taney will also be making a presentation on the Delcath PHP technology at the Investment in Innovation (In3) East Conference to be held on October 23rd, 9:30am-10:00am at the Westin Copley Place in Boston.
